JP6985282B2 - ７型コラーゲンの精製方法 - Google Patents

７型コラーゲンの精製方法 Download PDF

Info

Publication number
JP6985282B2
JP6985282B2 JP2018548754A JP2018548754A JP6985282B2 JP 6985282 B2 JP6985282 B2 JP 6985282B2 JP 2018548754 A JP2018548754 A JP 2018548754A JP 2018548754 A JP2018548754 A JP 2018548754A JP 6985282 B2 JP6985282 B2 JP 6985282B2
Authority
JP
Japan
Prior art keywords
collagen
recombinant human
human type
subjecting
solubilizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018548754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019511498A5 (https=
JP2019511498A (ja
Inventor
キノネス−ガルシア、イゴール
シメオネ、ベンジャミン
リリー、レイモンド
ヤン、ティン
ニコルス、デイビッド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoenix Tissue Repair Inc
Original Assignee
Phoenix Tissue Repair Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Tissue Repair Inc filed Critical Phoenix Tissue Repair Inc
Publication of JP2019511498A publication Critical patent/JP2019511498A/ja
Publication of JP2019511498A5 publication Critical patent/JP2019511498A5/ja
Priority to JP2021190717A priority Critical patent/JP7340583B2/ja
Application granted granted Critical
Publication of JP6985282B2 publication Critical patent/JP6985282B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2018548754A 2016-03-16 2017-03-10 ７型コラーゲンの精製方法 Active JP6985282B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021190717A JP7340583B2 (ja) 2016-03-16 2021-11-25 ７型コラーゲンの精製方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662309030P 2016-03-16 2016-03-16
US62/309,030 2016-03-16
PCT/US2017/021815 WO2017160636A1 (en) 2016-03-16 2017-03-10 Methods of purifying collagen 7

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021190717A Division JP7340583B2 (ja) 2016-03-16 2021-11-25 ７型コラーゲンの精製方法

Publications (3)

Publication Number Publication Date
JP2019511498A JP2019511498A (ja) 2019-04-25
JP2019511498A5 JP2019511498A5 (https=) 2020-04-16
JP6985282B2 true JP6985282B2 (ja) 2021-12-22

Family

ID=59852081

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018548754A Active JP6985282B2 (ja) 2016-03-16 2017-03-10 ７型コラーゲンの精製方法
JP2021190717A Active JP7340583B2 (ja) 2016-03-16 2021-11-25 ７型コラーゲンの精製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021190717A Active JP7340583B2 (ja) 2016-03-16 2021-11-25 ７型コラーゲンの精製方法

Country Status (7)

Country Link
US (1) US10669327B2 (https=)
EP (1) EP3429615A4 (https=)
JP (2) JP6985282B2 (https=)
CN (1) CN109069592B (https=)
CA (1) CA3015685A1 (https=)
MX (1) MX2018011162A (https=)
WO (1) WO2017160636A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108463470B (zh) * 2015-12-23 2021-10-22 菲尼克斯组织修复公司 胶原蛋白7的组合物及其使用方法
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
US10792618B2 (en) * 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
EP3953380A4 (en) 2019-04-12 2023-01-25 Geltor, Inc. RECOMBINATION ELASTIN AND ASSOCIATED PRODUCTION
EP4061446A4 (en) 2019-11-20 2023-11-29 NxStage Medical, Inc. METHODS, DEVICES AND SYSTEMS FOR PROVIDING PERITONEAL DIALYSIS LIQUID FROM A POWDERED CONCENTRATE
CN113121638B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种纯化重组蛋白的方法
GB2610313B (en) 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen
US11504716B2 (en) * 2020-06-05 2022-11-22 Pall Corporation Multiwell device and method of use
EP4225353A1 (en) * 2020-10-08 2023-08-16 Jellatech, Inc. Produce, isolate and/or extract collagen and/or gelatin from animal cell lines and/or tissue explants
KR20240004264A (ko) * 2021-03-04 2024-01-11 젤라텍, 인크. 배양된 동물 세포로부터의 콜라겐을 사용한 재료의 제조 방법
CN114805548B (zh) * 2021-12-29 2023-11-14 江苏创健医疗科技股份有限公司 一种重组胶原蛋白冻干纤维及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO599897A0 (en) * 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
US7855280B2 (en) 2005-09-15 2010-12-21 Wyeth Llc Separation methods
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
EP2753704A4 (en) * 2011-08-03 2015-07-08 Lotus Tissue Repair Inc COLLAGEN 7 AND ASSOCIATED METHODS
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US20140031295A1 (en) * 2012-07-19 2014-01-30 Lotus Tissue Repair, Inc. Recombinant C7 and Methods of Use
CN112126634A (zh) 2013-01-09 2020-12-25 夏尔人类遗传性治疗公司 含用于纯化芳基硫酸酯酶a的方法
KR20160055940A (ko) 2013-09-24 2016-05-18 엘라스타겐 피티와이 리미티드 단백질 추출 방법

Also Published As

Publication number Publication date
EP3429615A4 (en) 2019-11-06
CN109069592B (zh) 2023-03-07
JP2022016605A (ja) 2022-01-21
CA3015685A1 (en) 2017-09-21
CN109069592A (zh) 2018-12-21
EP3429615A1 (en) 2019-01-23
US10669327B2 (en) 2020-06-02
JP7340583B2 (ja) 2023-09-07
WO2017160636A1 (en) 2017-09-21
US20190077845A1 (en) 2019-03-14
JP2019511498A (ja) 2019-04-25
MX2018011162A (es) 2018-11-22

Similar Documents

Publication Publication Date Title
JP6985282B2 (ja) ７型コラーゲンの精製方法
CA2192683C (en) Filtration
JP5755136B2 (ja) 高濃度モノクローナル抗体溶液中のウイルス除去方法
US20180194801A1 (en) Method for isolating and purifying recombinant human serum albumin from transgenic rice grain
US20120282654A1 (en) Antibody purification
CN118994410A (zh) 通过将药物物质和药物产品过程整体化的生物制剂制造的连续制造过程
CN108350043A (zh) 用于产生肉毒杆菌毒素的方法
CN102245206A (zh) 获得无赋形剂抗体溶液的方法
CA2924042C (en) Method for the clarification of high density crude cell culture harvest
WO2022146856A1 (en) Systems and Methods for Process Scale Isolation of Immunoglobulin G
JP5274529B2 (ja) 組換えアンチトロンビンおよびその製造方法
JP2012112930A (ja) 高分子量物質の精製方法
CN1918289A (zh) 生产乳过氧化物酶的方法
AU682274C (en) Filtration
CN119300842A (zh) 通过超滤从血浆制备科恩池浓缩物的方法
WO2025173024A1 (en) Purification process and formulation of recombinant anti rhd monoclonal antibodies
Lütkemeyer et al. Microporous membrane ion exchanger for rapid purification of monoclonal antibodies

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200309

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210330

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210928

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211026

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211125

R150 Certificate of patent or registration of utility model

Ref document number: 6985282

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250